Therefore, further research elucidating the interaction of AML‐sEV‐derived YBX1 with other protein cargoes would help to understand the exact mechanism involved in the blockage of BM‐MSCs differentiation leading to AML progression that result in bone marrow failure. This evidence concerns the gene YBX1 and acute myeloid leukemia.